| Detected | Trial | Change |
|---|---|---|
| 2026-08-14 | NCT06808984 Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment… |
Trial sites expanded: 53 -> 75 locations |
| 2026-08-13 | NCT07459543 A Study to Assess the Safety, and Tolerability of Nivolumab + Relatlimab Fixed-Dose… |
Enrollment increased: 30 -> 40 participants |
| 2026-08-13 | NCT07459543 A Study to Assess the Safety, and Tolerability of Nivolumab + Relatlimab Fixed-Dose… |
Trial sites expanded: 8 -> 11 locations |
| 2026-08-13 | NCT07226817 A Study to Assess the Relative Bioavailability of BMS-986435 and Food Effect on the… |
Enrollment increased: 140 -> 240 participants |
| 2026-08-13 | NCT07226817 A Study to Assess the Relative Bioavailability of BMS-986435 and Food Effect on the… |
Trial arms changed: 7 -> 12 |
| 2026-08-12 | NCT07195682 A First-in-Human Study of BMS-986506 in Participants With Advanced Clear Cell Renal Cell… |
Enrollment increased: 125 -> 281 participants |
| 2026-08-12 | NCT07195682 A First-in-Human Study of BMS-986506 in Participants With Advanced Clear Cell Renal Cell… |
Trial arms changed: 3 -> 7 |
| 2026-08-12 | NCT06979453 A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165)… |
Trial sites expanded: 129 -> 132 locations |
| 2026-08-11 | NCT06926868 A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously… |
Primary endpoint(s) modified |
| 2026-08-11 | NCT06926868 A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously… |
Enrollment increased: 500 -> 600 participants |
| 2026-08-11 | NCT07361510 A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With… |
Trial sites expanded: 274 -> 278 locations |
| 2026-08-11 | NCT06067841 A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant… |
Trial sites expanded: 8 -> 15 locations |
| 2026-08-07 | NCT06112743 A Study to Evaluate Mavacamten Impact on Myocardial Structure in Participants With… |
date change Completion pushed: 2026-07-09 -> 2027-07-10 |
| 2026-08-05 | NCT06448793 Patient and Physician Preference Study in Resectable, Non-small Cell Lung Cancer… |
Trial completed |
| 2026-08-05 | NCT06448793 Patient and Physician Preference Study in Resectable, Non-small Cell Lung Cancer… |
Enrollment increased: 55 -> 650 participants |
| 2026-08-05 | NCT06448793 Patient and Physician Preference Study in Resectable, Non-small Cell Lung Cancer… |
date change Primary completion moved earlier: 2026-06-30 -> 2025-10-31 |
| 2026-08-05 | NCT06448793 Patient and Physician Preference Study in Resectable, Non-small Cell Lung Cancer… |
date change Completion moved earlier: 2026-06-30 -> 2025-10-31 |
| 2026-08-04 | NCT06220201 A Study to Evaluate the Safety, Tolerability, Efficacy, and Drug Levels of CC-97540 in… |
Enrollment closed, study ongoing |
| 2026-08-04 | NCT07335562 A Study to Compare the Efficacy and Safety of BMS-986353 (Zolacabtagene- Autoleucel /… |
overall status: Recruiting → Not Yet Recruiting |
| 2026-08-04 | NCT05869955 A Study of CC-97540, CD-19-Targeted Nex-T CAR T Cells, in Participants With Severe… |
Enrollment closed, study ongoing |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-08-13 | NCT07763418 A Study to Evaluate the Pharmacokinetics and Safety of Golcadomide in Participants With… | Phase 1 | Not Yet Recruiting |
| 2026-08-10 | NCT07755826 Repotrectinib Post-Marketing Surveillance in Pediatric Patients With NTRK Fusion-Positive… | Recruiting | |
| 2026-08-07 | NCT07752121 First-Line Luspatercept in Transfusion-Dependent Lower-Risk Myelodysplastic Neoplasms | Not Yet Recruiting | |
| 2026-07-29 | NCT07732907 Risk of Progressive Multifocal Leukoencephalopathy Among Patients With Multiple Sclerosis… | Recruiting | |
| 2026-07-23 | NCT07722507 Antifibrotic Therapy Decision-Making in Pulmonary Fibrosis | Not Yet Recruiting | |
| 2026-07-21 | NCT07718139 Demographics, Clinical Characteristics and Outcomes in Resected Non-Small Cell Lung… | Active, Not Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT06875960 | A Study to Continue the Administration of Deucravacitinib in Participants With Systemic… | Systemic Lupus Erythematosus (SLE) | Recruiting |
| NCT07221877 | A Study to Evaluate the Effect of KarXT on Urological Safety | Schizophrenia | Recruiting |
| NCT06396039 | A Study to Assess the Effectiveness and Safety of Ozanimod in Chinese Adults With… | Relapsing Multiple Sclerosis | Active, Not Recruiting |
| NCT05891249 | A Study to Evaluate the Safety and Effectiveness of Luspatercept for the Treatment of… | Anemia | Active, Not Recruiting |
| NCT07004972 | A Study of Mavacamten in Adults With Obstructive Hypertrophic Cardiomyopathy in India… | Symptomatic Obstructive Hypertrophic Cardiomyopathy | Active, Not Recruiting |
| NCT06112743 | A Study to Evaluate Mavacamten Impact on Myocardial Structure in Participants With… | Cardiomyopathy, Hypertrophic | Active, Not Recruiting |
| NCT07459543 | A Study to Assess the Safety, and Tolerability of Nivolumab + Relatlimab Fixed-Dose… | Unresectable Melanoma | Not Yet Recruiting |
| Phase 3 | |||
| NCT06408259 | Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in… | Multiple Sclerosis, Relapsing-Remitting | Recruiting |
| NCT06911502 | A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab… | Follicular Lymphoma | Recruiting |
| NCT04772079 | A Study to Evaluate the Drug Levels, Efficacy and Safety of Deucravacitinib in Children… | Plaque Psoriasis | Recruiting |
| NCT07140913 | A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of… | Mania | Recruiting |
| NCT04877288 | A Study to Evaluate the Benefits and Risks of Conversion of Existing Adolescent Kidney… | Renal Allograft Recipients | Recruiting |
| NCT06869551 | A Study to Evaluate the Drug Levels, Efficacy, and Safety of Deucravacitinib (BMS-986165)… | Juvenile Psoriatic Arthritis | Recruiting |
| NCT06976216 | A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment… | Alzheimer's Disease | Recruiting |
| NCT06947941 | A Study to Evaluate Safety and Efficacy of KarXT + KarX-EC as a Treatment for Psychosis… | Alzheimer Disease | Recruiting |
| NCT04064060 | A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other… | Myelodysplastic Syndromes (MDS) | Recruiting |
| NCT06561386 | A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs… | Non-small Cell Lung Cancer | Recruiting |
| NCT06951711 | A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes… | Bipolar Disorder Type I With Mania or Mania With Mixed Features | Recruiting |
| NCT06764485 | A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice… | Metastatic Castration-resistant Prostate Cancer | Recruiting |
| NCT06615479 | A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in… | Relapsed or Refractory Multiple Myeloma (RRMM) | Recruiting |
| NCT07116967 | Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With… | Plaque Psoriasis | Recruiting |
| NCT06929273 | A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in… | Bipolar Disorder Type I With Mania | Recruiting |
| NCT06882785 | A Study to Evaluate the Efficacy and Safety of KarXT in Acutely Psychotic Japanese Adult… | Schizophrenia | Recruiting |
| NCT06951698 | A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes… | Bipolar-I Disorder With Mania or Mania With Mixed Features | Recruiting |
| NCT06937229 | A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in… | Alzheimer Disease | Recruiting |